Literature DB >> 11248337

Partial, graded losses of dopamine terminals in the rat caudate-putamen: an animal model for the study of compensatory adaptation in preclinical parkinsonism.

B P Bergstrom1, K E Schertz, T Weirick, B Nafziger, S A Takacs, K O Lopes, K J Massa, Q D Walker, P A Garris.   

Abstract

Procedures to lesion dopamine (DA) neurons innervating the rat caudate-putamen (CP) in a partial, graded fashion are described in this study. The goal is to provide a lesion model that supports intra-animal comparisons of voltammetric recordings used to investigate compensatory adaptation of DA neurotransmission. Lesions exploited the topography of mesostriatal DA neurons, microinjections of the neurotoxin 6-hydroxydopamine (6-OHDA) into the medial and lateral edges of the ventral mesencephalon containing DA cell bodies and microdissection of the CP into six regions. Analysis of tissue DA content in these regions by HPLC-EC demonstrated that 6-OHDA injected into the lateral substantia nigra results in a significantly greater loss of DA in lateral versus medial regions of the CP. The direction of the graded loss of DA was reversed (i.e. a medial to lateral lesion gradient) by the injection of 6-OHDA into the ventral tegmental area near the medial SN. Extracellular concentrations of electrically evoked DA could be measured across the mediolateral axis of the CP in a single animal using the technique of in vivo voltammetry. More importantly, graded decreases in the amplitude of evoked DA levels generally followed the direction of the tissue DA gradient in lesioned animals. These results suggest that the graded loss of DA terminals in the CP, coupled to a spatially and temporally resolved technique for monitoring extracellular DA, is a viable tool for investigating compensatory adaptation in the mesostriatal DA system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11248337     DOI: 10.1016/s0165-0270(00)00372-1

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  8 in total

1.  α6ß2* and α4ß2* nicotinic receptors both regulate dopamine signaling with increased nigrostriatal damage: relevance to Parkinson's disease.

Authors:  Xiomara A Perez; Tanuja Bordia; J Michael McIntosh; Maryka Quik
Journal:  Mol Pharmacol       Date:  2010-08-23       Impact factor: 4.436

2.  Pre-synaptic dopaminergic compensation after moderate nigrostriatal damage in non-human primates.

Authors:  Xiomara A Perez; Neeraja Parameswaran; Luping Z Huang; Kathryn T O'Leary; Maryka Quik
Journal:  J Neurochem       Date:  2008-02-01       Impact factor: 5.372

3.  Methamphetamine neurotoxicity decreases phasic, but not tonic, dopaminergic signaling in the rat striatum.

Authors:  Christopher D Howard; Kristen A Keefe; Paul A Garris; David P Daberkow
Journal:  J Neurochem       Date:  2011-07-01       Impact factor: 5.372

4.  Behavioral, neurochemical, and electrophysiological changes in an early spontaneous mouse model of nigrostriatal degeneration.

Authors:  Paola Sgadò; Cristina Viaggi; Annalisa Pinna; Cristina Marrone; Francesca Vaglini; Silvia Pontis; Nicola Biagio Mercuri; Micaela Morelli; Giovanni Umberto Corsini
Journal:  Neurotox Res       Date:  2010-11-23       Impact factor: 3.911

5.  Functional reorganization of the presynaptic dopaminergic terminal in parkinsonism.

Authors:  B P Bergstrom; S G Sanberg; M Andersson; J Mithyantha; F I Carroll; P A Garris
Journal:  Neuroscience       Date:  2011-07-20       Impact factor: 3.590

Review 6.  Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesis.

Authors:  James W Bales; Amy K Wagner; Anthony E Kline; C Edward Dixon
Journal:  Neurosci Biobehav Rev       Date:  2009-04-01       Impact factor: 8.989

7.  Using in vivo voltammetry to demonstrate drug action: a student laboratory experience in neurochemistry.

Authors:  Brian P Bergstrom
Journal:  J Undergrad Neurosci Educ       Date:  2012-03-15

8.  Characterization of Fast-Scan Cyclic Voltammetric Electrodes Using Paraffin as an Effective Sealant with In Vitro and In Vivo Applications.

Authors:  Eric S Ramsson; Daniel Cholger; Albert Dionise; Nicholas Poirier; Avery Andrus; Randi Curtiss
Journal:  PLoS One       Date:  2015-10-27       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.